Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK.
Earl HM, Hiller L, Dunn J, Macpherson I, Rea D, Hughes-Davies L, McAdam K, Hall P, Mansi J, Wheatley D, Abraham JE, Caldas C, Gasson S, O'Riordan E, Wilcox M, Miles D, Cameron DA, Wardley A. Earl HM, et al. Clin Oncol (R Coll Radiol). 2021 Jan;33(1):15-19. doi: 10.1016/j.clon.2020.07.006. Epub 2020 Jul 25. Clin Oncol (R Coll Radiol). 2021. PMID: 32723485 Free PMC article. No abstract available.
Mitomycin, ifosfamide and cisplatin in non-small-cell lung cancer.
Currie DC, Miles DW, Drake JS, Rudd R, Spiro SG, Earl HM, Harper PG, Tobias JS, Souhami RL. Currie DC, et al. Among authors: earl hm. Cancer Chemother Pharmacol. 1990;25(5):380-1. doi: 10.1007/BF00686243. Cancer Chemother Pharmacol. 1990. PMID: 2155066
Etoposide protein binding in cancer patients.
Liu B, Earl HM, Poole CJ, Dunn J, Kerr DJ. Liu B, et al. Among authors: earl hm. Cancer Chemother Pharmacol. 1995;36(6):506-12. doi: 10.1007/BF00685801. Cancer Chemother Pharmacol. 1995. PMID: 7554043
Chemotherapy of malignant fibrous histiocytoma of bone.
Earl HM, Pringle J, Kemp H, Morittu L, Miles D, Souhami R. Earl HM, et al. Ann Oncol. 1993 May;4(5):409-15. doi: 10.1093/oxfordjournals.annonc.a058521. Ann Oncol. 1993. PMID: 8394734 Free article. Clinical Trial.
A phase II study of Tomudex in relapsed epithelial ovarian cancer.
Gore ME, Earl HM, Cassidy J, Tattersall M, Mansi J, Seymour L, Azab M. Gore ME, et al. Among authors: earl hm. Ann Oncol. 1995 Sep;6(7):724-5. doi: 10.1093/oxfordjournals.annonc.a059291. Ann Oncol. 1995. PMID: 8664196 Free article. Clinical Trial. No abstract available.
Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: an anglo-celtic cooperative oncology group study.
Evans TR, Yellowlees A, Foster E, Earl H, Cameron DA, Hutcheon AW, Coleman RE, Perren T, Gallagher CJ, Quigley M, Crown J, Jones AL, Highley M, Leonard RC, Mansi JL. Evans TR, et al. J Clin Oncol. 2005 May 1;23(13):2988-95. doi: 10.1200/JCO.2005.06.156. J Clin Oncol. 2005. PMID: 15860854 Clinical Trial.
Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer.
Poole CJ, Earl HM, Hiller L, Dunn JA, Bathers S, Grieve RJ, Spooner DA, Agrawal RK, Fernando IN, Brunt AM, O'Reilly SM, Crawford SM, Rea DW, Simmonds P, Mansi JL, Stanley A, Harvey P, McAdam K, Foster L, Leonard RC, Twelves CJ; NEAT Investigators and the SCTBG. Poole CJ, et al. Among authors: earl hm. N Engl J Med. 2006 Nov 2;355(18):1851-62. doi: 10.1056/NEJMoa052084. N Engl J Med. 2006. PMID: 17079759 Free article. Clinical Trial.
Pharmacogenetics of cancer chemotherapy.
Abraham J, Earl HM, Pharoah PD, Caldas C. Abraham J, et al. Among authors: earl hm. Biochim Biophys Acta. 2006 Dec;1766(2):168-83. doi: 10.1016/j.bbcan.2006.10.003. Epub 2006 Oct 25. Biochim Biophys Acta. 2006. PMID: 17141416 Review.
140 results